| Enumeration and Characterization of Antimicrobial-Resistant Escherichia coli Bacteria in Effluent from Municipal, Hospital, and Secondary Treatment Facility Sources S Galvin, F Boyle, P Hickey, A Vellinga, D Morris, M Cormican Applied and environmental microbiology 76 (14), 4772-4779, 2010 | 271 | 2010 |
| Trial forge guidance 1: what is a study within a trial (SWAT)? S Treweek, S Bevan, P Bower, M Campbell, J Christie, M Clarke, C Collett, ... Trials 19, 1-5, 2018 | 215 | 2018 |
| Microbial monitoring of the hospital environment: why and how? S Galvin, A Dolan, O Cahill, S Daniels, H Humphreys Journal of Hospital Infection 82 (3), 143-151, 2012 | 134 | 2012 |
| Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? N O'connor, O Cahill, S Daniels, S Galvin, H Humphreys Journal of hospital infection 88 (2), 59-65, 2014 | 132 | 2014 |
| Identifying trial recruitment uncertainties using a James Lind Alliance priority setting partnership–the PRioRiTy (Prioritising recruitment in randomised trials) study P Healy, S Galvin, PR Williamson, S Treweek, C Whiting, B Maeso, ... Trials 19, 1-12, 2018 | 122 | 2018 |
| Air and surface contamination patterns of meticillin-resistant Staphylococcus aureus on eight acute hospital wards E Creamer, AC Shore, EC Deasy, S Galvin, A Dolan, N Walley, S McHugh, ... Journal of Hospital Infection 86 (3), 201-208, 2014 | 70 | 2014 |
| Using qualitative insights to change practice: exploring the culture of antibiotic prescribing and consumption for urinary tract infections S Duane, C Domegan, A Callan, S Galvin, M Cormican, K Bennett, ... BMJ open 6 (1), e008894, 2016 | 69 | 2016 |
| What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in … D Brunsdon, L Biesty, P Brocklehurst, V Brueton, D Devane, J Elliott, ... Trials 20, 1-12, 2019 | 62 | 2019 |
| Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial A Vellinga, S Galvin, S Duane, A Callan, K Bennett, M Cormican, ... Cmaj 188 (2), 108-115, 2016 | 61 | 2016 |
| Enterococcus faecium of the vanA Genotype in Rural Drinking Water, Effluent, and the Aqueous Environment D Morris, S Galvin, F Boyle, P Hickey, M Mulligan, M Cormican Applied and environmental microbiology 78 (2), 596-598, 2012 | 41 | 2012 |
| Evaluation of vaporized hydrogen peroxide, Citrox and pH neutral Ecasol for decontamination of an enclosed area: a pilot study S Galvin, M Boyle, RJ Russell, DC Coleman, E Creamer, JP O’Gara, ... Journal of Hospital Infection 80 (1), 67-70, 2012 | 40 | 2012 |
| Improving trial recruitment processes: how qualitative methodologies can be used to address the top 10 research priorities identified within the PRioRiTy study M Hennessy, A Hunter, P Healy, S Galvin, C Houghton Trials 19, 1-5, 2018 | 39 | 2018 |
| Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed S Treweek, S Bevan, P Bower, M Briel, M Campbell, J Christie, C Collett, ... Trials 21, 1-9, 2020 | 34 | 2020 |
| Exploratory Spatial Mapping of the Occurrence of Antimicrobial Resistance in E. coli in the Community S Galvin, N Bergin, R Hennessy, B Hanahoe, AW Murphy, M Cormican, ... Antibiotics 2 (3), 328-338, 2013 | 29 | 2013 |
| Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital E Creamer, S Galvin, A Dolan, O Sherlock, BD Dimitrov, ... American journal of infection control 40 (5), 411-415, 2012 | 28 | 2012 |
| What is the best method? Recovery of methicillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase–producing Escherichia coli from inanimate hospital surfaces T Claro, S Galvin, O Cahill, D Fitzgerald-Hughes, S Daniels, ... Infection Control & Hospital Epidemiology 35 (7), 869-871, 2014 | 26 | 2014 |
| The antimicrobial effects of helium and helium–air plasma on Staphylococcus aureus and Clostridium difficile S Galvin, O Cahill, N O'Connor, AA Cafolla, S Daniels, H Humphreys Letters in applied microbiology 57 (2), 83-90, 2013 | 25 | 2013 |
| Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial S Duane, A Callan, S Galvin, AW Murphy, C Domegan, E O’Shea, ... Trials 14, 1-13, 2013 | 22 | 2013 |
| Search and you will find: detecting extended-spectrum β-lactamase–producing Klebsiella pneumoniae from a patient's immediate environment C Judge, S Galvin, L Burke, T Thomas, H Humphreys, ... Infection Control & Hospital Epidemiology 34 (5), 534-536, 2013 | 22 | 2013 |
| The PROMoting the USE of SWATs (PROMETHEUS) programme: Lessons learnt and future developments for SWATs L Clark, C Arundel, E Coleman, L Doherty, A Parker, C Hewitt, D Beard, ... Research Methods in Medicine & Health Sciences 3 (4), 100-106, 2022 | 12 | 2022 |
